Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Evaluating the effects of Quebec's private-public drug insurance system.

Morgan SG, Gagnon MA, Charbonneau M, Vadeboncoeur A.

CMAJ. 2017 Oct 10;189(40):E1259-E1263. doi: 10.1503/cmaj.170726. Review. No abstract available.

PMID:
29018085
2.

Potential bias in medication adherence studies of prevalent users.

Maciejewski ML, Bryson CL, Wang V, Perkins M, Liu CF.

Health Serv Res. 2013 Aug;48(4):1468-86. doi: 10.1111/1475-6773.12043. Epub 2013 Feb 13.

3.

Assessing barriers to health insurance and threats to equity in comparative perspective: the Health Insurance Access Database.

Quesnel-Vallée A, Renahy E, Jenkins T, Cerigo H.

BMC Health Serv Res. 2012 Jul 10;12:107. doi: 10.1186/1472-6963-12-107.

4.

How patient cost-sharing trends affect adherence and outcomes: a literature review.

Eaddy MT, Cook CL, O'Day K, Burch SP, Cantrell CR.

P T. 2012 Jan;37(1):45-55.

5.

Relationship of asthma management, socioeconomic status, and medication insurance characteristics to exacerbation frequency in children with asthma.

Ungar WJ, Paterson JM, Gomes T, Bikangaga P, Gold M, To T, Kozyrskyj AL.

Ann Allergy Asthma Immunol. 2011 Jan;106(1):17-23. doi: 10.1016/j.anai.2010.10.006. Epub 2010 Nov 20.

6.

What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries.

Gemmill MC, Thomson S, Mossialos E.

Int J Equity Health. 2008 May 2;7:12. doi: 10.1186/1475-9276-7-12.

7.

Effect of cost-sharing on use of asthma medication in children.

Ungar WJ, Kozyrskyj A, Paterson M, Ahmad F.

Arch Pediatr Adolesc Med. 2008 Feb;162(2):104-10. doi: 10.1001/archpediatrics.2007.21.

8.

Modeling the potential impact of a prescription drug copayment increase on the adult asthmatic medicaid population.

Bae SJ, Paltiel AD, Fuhlbrigge AL, Weiss ST, Kuntz KM.

Value Health. 2008 Jan-Feb;11(1):110-8. doi: 10.1111/j.1524-4733.2007.00219.x.

Supplemental Content

Support Center